A randomized, double‐blind clinical trial to evaluate the efficacy and safety of a fixed‐dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension-Reference-Cited by-同舟云学术

A randomized, double‐blind clinical trial to evaluate the efficacy and safety of a fixed‐dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension

Published:2020-01-31 Issue:2 Volume:22 Page:261-269
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:J Clin Hypertens

Author:

Kim Woohyeun¹,Chang Kiyuk²,Cho Eun Joo³,Ahn Jeong‐Cheon⁴,Yu Cheol Woong⁵,Cho Kyoung‐Im⁶,Kim Yong‐Jin⁷,Kang Duk‐Hyun⁸,Kim Seok‐Yeon⁹,Lee Sang‐Hak¹⁰,Kim Ung¹¹,Kim Shin‐Jae¹²,Ahn Young Keun¹³,Lee Chang Hoon¹⁴,Shin Jin Ho¹⁵^ORCID,Kim Mikyung¹⁶,Park Chang Gyu¹^ORCID

Affiliation:

1. Cardiovascular Center Korea University Guro Hospital Seoul Korea

2. Division of Cardiology Seoul St. Mary's Hospital Seoul Korea

3. Division of Cardiology St. Paul's Hospital Seoul Korea

4. Division of Cardiology Korea University Ansan Hospital Ansan Korea

5. Division of Cardiology Korea University Anam Hospital Seoul Korea

6. Division of Cardiology Maryknoll Medical Center Busan Korea

7. Cardiovascular Center Seoul National University Hospital Seoul Korea

8. Valvular Heart Disease Center Asan Medical Center Heart Institute Seoul Korea

9. Department of Cardiology Seoul Medical Center Seoul Korea

10. Division of Cardiology Severance Cardiovascular Hospital Seoul Korea

11. Division of Cardiology Yeungnam University Medical Center Daegu Korea

12. Division of Cardiology Ulsan University Hospital Ulsan Korea

13. Heart Center of Chonnam National University Hospital Gwangju Korea

14. Division of Cardiology Veterans Health Service Medical Center Seoul Korea

15. Division of Cardiology Hanyang University Hospital Seoul Korea

16. Yuhan Research Institute Yuhan Corporation Yongin Korea

Funder

Yuhan Corporation

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jch.13774

Reference39 articles.

1. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

2. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

3. Management of Hypertension and Dyslipidemia for Primary Prevention of Cardiovascular Disease

4. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APHA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Whelton PK;Hypertension,2018

5. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of genetic variants related to combined lipid-lowering and antihypertensive therapies with risk of cardiovascular disease: 2 × 2 factorial Mendelian randomization analyses;BMC Medicine;2024-05-20

2. Statins As Anti-Hypertensive Therapy: A Systematic Review and Meta-Analysis;Cureus;2024-04-08

3. Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular disease;Nature Medicine;2024-03-26

4. The Impact of Polypill on Adherence and Cardiovascular Outcomes: A Comprehensive Systematic Review with Meta-Analysis;Current Cardiology Reviews;2024-03

5. Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients with Dyslipidemia and Hypertension: A Multicenter Randomized Clinical Trial;Current Therapeutic Research;2024